RecruitingNot applicableNCT03653650

Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidad Autonoma de Nuevo Leon
Principal Investigator
Karim Mohamed-Noriega, M.D.
Departamento de Oftalmologia, Hospital Universitario Dr. Jose Eleuterio Gonzalez
Intervention
PRP plus BCL(combination_product)
Enrollment
54 target
Eligibility
All sexes
Timeline
20182025

Study locations (1)

Collaborators

Hospital Universitario Dr. Jose E. Gonzalez

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03653650 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials